MindMaze Therapeutics Holding SA

Research MindMaze Therapeutics Holding SA (V6M) on Bullrun: market cap EUR 2.43M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 2.43M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2024CHF 8.42M-CHF 17.12M-CHF 3.09M69.4%-1.37CHF 15.08MCHF 2.14MCHF 36.66M
FY2023CHF 6.03M-CHF 98.18M-CHF 18.06M71.2%-8.35CHF 14.56MCHF 2.96MCHF 52.23M
FY2022CHF 6.08M-CHF 50.79M-CHF 24.65M79.4%-4.81CHF 19.24MCHF 3.06MCHF 145.42M
FY2021CHF 3.32M-CHF 34.71M-CHF 49.43M-495.4%-4CHF 44.76MCHF 3.01MCHF 181.53M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-09-12EUR 2.43Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About MindMaze Therapeutics Holding SA

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings;

Related stock research

Other Financial Services stocks

Frequently asked questions

What is MindMaze Therapeutics Holding SA's market cap?

MindMaze Therapeutics Holding SA's market capitalization is EUR 2.43M.

What does MindMaze Therapeutics Holding SA do?

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.